Viewing Study NCT01922895


Ignite Creation Date: 2025-12-24 @ 2:03 PM
Ignite Modification Date: 2025-12-28 @ 4:41 AM
Study NCT ID: NCT01922895
Status: TERMINATED
Last Update Posted: 2022-03-02
First Post: 2013-08-12
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Novel Therapies in Moderately Severe Acute Alcoholic Hepatitis
Sponsor: University of Texas Southwestern Medical Center
Organization:

Study Overview

Official Title: Novel Therapies in Moderately Severe Acute Alcoholic Hepatitis
Status: TERMINATED
Status Verified Date: 2022-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Lack of funding
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: NTAH-Mod
Brief Summary: This study is being done to find out whether a diet supplemented with a probiotic nutrient can improve alcoholic hepatitis and gut complications compared to routine standard care.
Detailed Description: Aim 1: Evaluate the effects of probiotic supplements on improvement in MELD score and gut mucosal integrity in patients with MELD \< 21. Patients will be randomized to receive daily probiotics for 6 months and standard of care treatment or placebo with standard care.

Aim 2: Document the natural history of moderately severe alcoholic hepatitis. Patients who decline randomization will be offered the option of inclusion in the study prospectively for data collection purposes and research study procedures.

Aim 3: Create a data and tissue biorepository. This biorepository will serve as a national resource for studies related to acute alcoholic hepatitis.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
U01AA021893-01 NIH None https://reporter.nih.gov/quic… View